Hyperbaric Oxygen Therapy Adjuvant Chemotherapy and Radiotherapy through Inhibiting Stemness in Glioblastoma

• Published in: Current Issues in Molecular Biology Vol. 45; no. 10; pp. 8309 - 8320
• Main Authors: Yuen, Chun-Man, Tsai, Hung-Pei, Tseng, Tzu-Ting, Tseng, Yu-Lung, Lieu, Ann-Shung, Kwan, Aij-Lie, Chang, Alice Y. W
• Format: Journal Article
• Language: English
• Published: MDPI AG 01.10.2023; MDPI
• Subjects: Adjuvant treatment; Brain tumors; Cancer; GBM; Glioblastoma multiforme; Health aspects; hyperbaric oxygen therapy; Immunohistochemistry; Radiotherapy; Stem cells; stemness; Television programs; TMZ; Transplantation; Taiwan
• ISSN: 1467-3045; 1467-3037; 1467-3045
• DOI: 10.3390/cimb45100524

Glioblastoma multiforme (GBM) is the most common and deadliest primary brain tumor in adults. Despite the advances in GBM treatment, outcomes remain poor, with a 2-year survival rate of less than 5%. Hyperbaric oxygen (HBO) therapy is an intermittent, high-concentration, short-term oxygen therapy used to increase cellular oxygen content. In this study, we evaluated the effects of HBO therapy, alone or combined with other treatment modalities, on GBM in vitro and in vivo. In the in vitro analysis, we used a 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay to assess the effects of HBO therapy alone, a colony formation assay to analyze the effects of HBO therapy combined with radiotherapy and with temozolomide (TMZ), and a neurosphere assay to assess GBM stemness. In the in vivo analysis, we used immunohistochemical staining and in vivo bioluminescence imaging to assess GBM stemness and the therapeutic effect of HBO therapy alone or combined with TMZ or radiotherapy, respectively. HBO therapy did not affect GBM cell viability, but it did reduce the analyzed tumors’ ability to form cancer stem cells. In addition, HBO therapy increased GBM sensitivity to TMZ and radiotherapy both in vitro and in vivo. HBO therapy did not enhance tumor growth and exhibited adjuvant effects to chemotherapy and radiotherapy through inhibiting GBM stemness. In conclusion, HBO therapy shows promise as an adjuvant treatment for GBM by reducing cancer stem cell formation and enhancing sensitivity to chemotherapy and radiotherapy.